Maryanne O'Hara
Author
AMR Patient Advocate
Lesley Ogilvie
Scientific Programme Officer
Global AMR R&D Hub
Cary Adams
CEO
The Union for International Cancer Control
Cary Adams
CEO
The Union for International Cancer Control
Fleur Anderson
Member Of Parliament
House of Commons
Yuri Martina
CMO
Destiny Pharma
Tim Walsh
Research Director
Oxford University
Professor Tim Walsh has been studying antimicrobial resistance (AMR) mechanisms for over 25 years and publishes regularly in Nature and Lancet journals. Notably, in his career he has discovered and named two of the most notorious antibiotic resistant genes – NDM-1 and MCR-1. His work also helped discover the mobile tigecycline gene (tetX variant).
Vikas Aggarwal
Regional Director, Asia
Fleming Fund
Toby Leslie
Health Specialist
Fleming Fund
Martin Sutherland
Director and General Manager
IDEXX